Cargando…
Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation
OBJECTIVES: To compare the clinical effects of Osimertinib and Gefitinib in the treatment of non-small cell lung (NSCLC) complicated with epidermal growth factor receptor (EGFR) gene mutation. METHODS: We retrospectively analyzed the clinical data of 102 patients with advanced NSCLC and EGFR gene mu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Professional Medical Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378400/ https://www.ncbi.nlm.nih.gov/pubmed/35991226 http://dx.doi.org/10.12669/pjms.38.6.5456 |